Drugs / PDFE-2304
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07011485 | May → Aug 2025 overdue | androgenetic alopecia | PDFE Pharma Innovations FZCO | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PDFE-2304 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07011485 ↗ |
| Route | Topical | “PDFE-2304 Topical Solution” NCT07011485 ↗ |